US President Trump extends Transition Period for EtO Sterilisation
Sterilisation with ethylene oxide (EtO) is widely used in the medical device sector, although the technology is controversial for environmental reasons. There is an extraordinary measure in the USA to achieve an extension of the status quo for medical device sterilisation companies and thus circumvent stricter environmental regulations. The initiator is US President Trump. What does Trump have in mind?
Ethylene oxide sterilisation and its emissions are regulated in the USA by the Environmental Protection Agency (EPA), among others. A recently published and very comprehensive document entitled 'National Emission Standards for Hazardous Air Pollutants: Ethylene Oxide Emissions Standards for Sterilisation Facilities Residual Risk and Technology Review' sets the course for the future. The plan is to provide greater protection for the population from EtO emissions, which in turn would also lead to significant investments by EtO sterilisation companies.
This is precisely how President Trump sees it. Around 50 per cent of all sterile medical devices in the United States are sterilised with ethylene oxide. In some cases, it is the only method of sterilising medical devices without damaging them. By requiring compliance with standards, the EtO regulation carries the risk that important sterile medical devices will no longer be available for care. A supply bottleneck is looming.
President Trump's measure
President Trump has issued a proclamation entitled 'REGULATORY RELIEF FOR CERTAIN STATIONARY SOURCES TO PROMOTE AMERICAN SECURITY WITH RESPECT TO STERILE MEDICAL EQUIPMENT'. It once again points out the danger of a supply bottleneck for medical devices and therefore grants a two-year deferral as an exemption for various sterilisation companies listed in Annex I.
Conclusion: With this exemption, US President Trump is allowing certain EtO sterilisation companies to continue with their current procedures for two years and not have to comply with the stricter environmental regulations. He believes that this measure will prevent a supply shortage of sterile medical devices in the US. The measure also demonstrates President Trump's industry-friendly stance towards domestic industry.
Related GMP News
27.05.2026Survey Results from Team Notified Body on the MDR and IVDR
27.05.2026FDA Q&A Document on the new GMP Regulations for Medical Devices
27.05.2026CDRH Annual Report 2025
13.01.2026MDCG publishes Guidance on the Surveillance of Medical Devices and IVDs
13.01.2026Real-world Evidence Data now also expanded in the Field of Medical Devices
06.11.2025FDA Warning Letter Statistics on Medical Devices in the Past Fiscal Year 2025



